Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia 54Myelodysplastic Syndromes 41Lymphoma, Non-Hodgkin 15Congenital Abnormalities 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma 12Recurrence 11Leukemia, Myelomonocytic, Chronic 11Hodgkin Disease 11Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Megakaryoblastic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Biphenotypic, Acute 9Hematologic Neoplasms 9Neoplasms 7Anemia, Refractory, with Excess of Blasts 7Multiple Myeloma 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Graft vs Host Disease 5Burkitt Lymphoma 5Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4

Interventions

Imatinib Mesylate 14Dasatinib 5nilotinib 4bosutinib 4Cyclophosphamide 4fludarabine 3Vincristine 3Methotrexate 3Dexamethasone 3Cytarabine 3peginterferon alfa-2a 2fludarabine phosphate 2asciminib 2Prednisone 2Daunorubicin 2Azacitidine 2Acetaminophen 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2venetoclax 1thymoglobulin 1ponatinib 1olverembatinib 1flumatinib 1blinatumomab 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Rituximab 1Prednisolone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Philadelphia Chromosome × Clofarabine × Other hematologic neoplasm × Clear all
NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡